<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">On the other hand, S protein depletes in binding to ACE2, leading to myocardial damage mediated by ACE/ACE2 imbalance in vivo [
 <xref ref-type="bibr" rid="CR45">45</xref>]. ACE2 is a homolog of ACE, but their functions are entirely different [
 <xref ref-type="bibr" rid="CR46">46</xref>]. ACE-mediated endocrine regulation causes vasoconstriction and increased blood pressure through the ACE⁃AngII (Angiotensin II)⁃AT1 axis [
 <xref ref-type="bibr" rid="CR47">47</xref>]. The ACE2⁃Ang 1⁃7⁃Mas axis mediated by ACE2 can antagonize the above effects [
 <xref ref-type="bibr" rid="CR48">48</xref>]. AngII, as an inflammatory factor regulatory protein, plays an essential regulatory role in mediating myocardial injury, and ACE2 has a protective effect in organs such as the heart and kidney [
 <xref ref-type="bibr" rid="CR45">45</xref>]. It is theoretically speculated that SARS⁃CoV⁃2 reduces the expression of ACE2 after infecting cardiomyocytes through S protein, causing an increase in AngII level, which results in cardiomyocyte damage and apoptosis.
</p>
